Clinical trial
Intranasal Recombinant Flagellin Subunit Campylobacter Vaccine (rFla-MBP)…
NCT00124865 · U.S. Army Medical Research and Development Command, U.S. Fed · Withdrawn
Key facts
| NCT number | NCT00124865 |
|---|---|
| Title | Intranasal Recombinant Flagellin Subunit Campylobacter Vaccine (rFla-MBP) Dose-Ranging Study |
| Official title | Safety and Immunogenicity Evaluation of an Intranasal Recombinant Flagellin Subunit Campylobacter Vaccine (rFla-MBP) in Volunteers |
| Lead sponsor | U.S. Army Medical Research and Development Command, U.S. Fed |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Diarrhea |
| Intervention type | Biological |
| Interventions | rFla-MBP |
| Enrollment | 0 |
| Start date | Jul 1, 2005 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Jul 28, 2005 |
| Last update posted | Sep 26, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: